This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • COVID-19
  • /
  • Safety and efficacy of inhaled nebulised interfero...
Journal

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Read time: 1 mins
Published:11th Nov 2020
Author: Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M et al.
Availability: Free full text
Ref.:Lancet Respir Med. 2020 Nov 12:S2213-2600(20)30511-7.
DOI:10.1016/S2213-2600(20)30511-7
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest